THE DATA FOR ADULT DRUG TREATMENT LINCOLNSHIRE LINCOLNSHIRE E08B 32



Similar documents
Alcohol and drugs JSNA support pack

drug treatment in england: the road to recovery

The story of drug treatment

THE STORY OF DRUG TREATMENT

FALLING DRUG USE: THE IMPACT OF TREATMENT

Why invest? How drug treatment and recovery services work for individuals, communities and society

Treat addiction, cut crime. How treatment and recovery services reduce drug-related offending

REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS

Adult drug treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities

Principles for commissioning a substance misuse treatment system

BUILDING RECOVERY IN COMMUNITIES

Addressing Alcohol and Drugs in the Community. Cabinet member: Cllr Keith Humphries - Public Health and Protection Services

POWDER COCAINE: HOW THE TREATMENT SYSTEM IS RESPONDING TO A GROWING PROBLEM

DRUG TREATMENT 2012: PROGRESS MADE, CHALLENGES AHEAD

Trends in Drug Treatment

Adult drug treatment plan 2007/08 Part 1 Section A: Strategic summary Section B: National targets Section C: Partnership performance expectations

2. Local Data to reduce Alcohol Related Harm and Comparison Groups

Alcohol and drugs prevention, treatment and recovery: why invest?

Protecting and improving the nation s health. Drug treatment in England

The Government's Drug Strategy

MAKING RECOVERY REAL: THE PUBLIC HEALTH FUTURE OF DRUG AND ALCOHOL TREATMENT

Adults who misuse drugs and alcohol

Bsafe Blackpool Community Safety and Drugs Partnership. Drug and Alcohol treatment planning in the community for Young People and Adults 2012/13

Treatment Approaches for Drug Addiction

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW

Sheffield Future Commissioning of Drug & Alcohol Community Treatment

Safer Stronger Communities Select Committee

THE ROLE OF RESIDENTIAL REHAB IN AN INTEGRATED TREATMENT SYSTEM

A LONG-TERM STUDY OF THE OUTCOMES OF DRUG USERS LEAVING TREATMENT SEPTEMBER 2010

Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP

Drug addic+on is a complex but treatable condi+on Addicts use drugs compulsively, damaging themselves and those around them

Models of care for treatment of adult drug misusers: Update 2006

Treatment Approaches for Drug Addiction

Dual Diagnosis. Dual Diagnosis Good Practice Guidance, Dept of Health (2002);

About Public Health England

Islington JSNA 2010/11 Substance Misuse

Costing report. Drug misuse: psychosocial interventions and opioid detoxification. Implementing NICE guidance. July 2007

Specialist drug and alcohol services for young people a cost benefit analysis

Substance Misuse. See the Data Factsheets for more data and analysis:

Topic Area - Dual Diagnosis

National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET H

Adult Drug Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2013 to 31 March 2014

REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY. The New York Community Trust April 2003

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse

addiction to medicine

Business Case for Contribution to LDAAT Drug Intervention Programme (DIP)

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

HIGH SUCCESS RATE OF BUTTERY REHABILITATION PROGRAMS

Reducing Drug Use, Reducing Reoffending Are programmes for problem drug-using offenders in the UK supported by the evidence?

DWP. Putting Full Recovery First

Gateshead PCT. Adult Drug and Alcohol Treatment Needs Assessment 2011/2012

London: boom or bust

Croydon Drug and Alcohol Action Team

Oxfordshire Drug and Alcohol Treatment System

Analysis of survey data on the implementation of NICE PH18 guidance relating to needle and syringe provision in England

Building recovery in communities:

Consultation on Future Drug and Alcohol Services in Shropshire

Reshaping Drug and Alcohol Treatment in Westminster. Public Consultation

Preventing and responding to dependence on prescribed and over-the-counter medicines: national policy, local action

Consultation Paper on Commissioning Adults and Young People s Drug and Alcohol Services in Somerset

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.

BUILDING RECOVERY IN COMMUNITIES

SERVICE SPECIFICATION FOR THE PROVISION OF DELIVERY OF SERVICES FOR DRUG AND ALCOHOL TREATMENT AND RECOVERY. (Schedule 1 of the Agreement)

Queensland Corrective Services Drug and Alcohol Policy

The Isle of Wight Drugs and Alcohol Needs Assessment 2013

Integrated drug treatment system Treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities

Joint Committee on Health and Children

Phoenix Futures Prison Treatment programmes

Clinical Priorities for Alcohol and Drugs in Public Health

Lincolnshire Alcohol and Drug Strategy

Understanding the Costs and Savings to Public Services of Different Treatment Pathways for Clients Dependent on Opiates

Drugs and Alcohol - Commissioning for an integrated treatment, recovery support and care coordination service

Best practice guidance for commissioners and providers of pharmaceutical services for drug users. Service specification (Tier 2 or 3)

An independent review into the impact on employment outcomes of drug or alcohol addiction, and obesity. Call for evidence

The Recovery Pathway Service forms a key component of the Sunderland Integrated Substance Misuse Service, as illustrated below:

Specialist drug and alcohol services for young people a cost benefit analysis

1. Residential Rehabilitation Services in Brighton and Hove

Models of care. for treatment of adult drug misusers. Framework for developing local systems of effective drug misuse treatment in England

Specialist Alcohol & Drug Services in Lanarkshire

European report on drug consumption rooms Executive summary

Guidance on commissioning young people s specialist substance misuse treatment services

7.11 Substance misuse

DRUG STRATEGY On 8 December the government launched its new drug strategy.

estimating the crime reduction benefits of drug treatment and recovery

Statistics from the National Drug Treatment Monitoring System (NDTMS) Statistics relating to young people England, 1 April March 2011

Treatments for drug misuse

drug dependence treatment and care

NTA business plan

People affected by drug and alcohol misuse

Cost Analysis in Drug Addiction: methods and results

Substance misuse among young people in England

Getting help for a drug problem A guide to treatment

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center

Directory for Substance Misuse Services in Caerphilly

Drug abuse in the Republic of Ireland: an overview

SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011

FROM ACCESS TO RECOVERY: ANALYSING SIX YEARS OF DRUG TREATMENT DATA

Alcohol data: JSNA support pack

THE INDEPENDENCE INITIATIVE: AN EVALUATION OF EFFECTIVENESS EXECUTIVE SUMMARY Jim McVeigh & Paul Duffy. Foreword

The National Treatment Agency for Substance Misuse s (NTA) written statement to Health Select Committee inquiry into Public Health

Transcription:

THE DATA FOR ADULT DRUG TREATMENT LINCOLNSHIRE LINCOLNSHIRE E08B 32

THIS SUPPORTING INFORMATION This pack sets out the investment in drug in your area. It also gives key performance information about your system and national data for comparison. It presents data from the Drug Treatment Monitoring System (NDTMS), the Treatment Outcomes Profile (TOP), the Drug Interventions Programme (DIP) and estimates of the prevalence of opiate and/or crack cocaine use. Although drug services treat dependence for all drugs, heroin users remain the group with most complex problems, so separate data is provided for them. INVESTMENT Investment in drug in your area for 2011-12 and 2012-13 is set out below. This includes allocations for the Pooled Treatment Budget (PTB, the central government contribution to funding for adult in your area); historic DIP funding (which engages drug-using offenders in ); prison drug (where there is a prison in your area, 2010-11 funding not included); and, where it has been provided to the NTA, mainstream PCT contributions to drug ; plus other local funding sources. Some local areas have not provided mainstream and other figures, in which case the actual total is likely be higher than that shown. PTB allocations are based on drug system performance. areas have attracted more drug funding by effectively engaging more people in, and helping them recover. 20% of funding for 2012-13 was based on the number successfully completing and not returning. The Advisory Committee for Resource ocation has advised that the broad methodology (praised as effective by the Audit Office) should continue to be a component of the public health grant which will flow to Authorities in 2013-14. 2012-13 2011-12 Change from 2011-12 Investment in drug PTB 3,641,826 3,423,739 6.4% DoH DIP HO DIP 312,792 166,563 493,839-2.9% 2011-12 Prison 1,797,331 1,578,695 13.8% 2012-13 Mainstream 1,045,400 1,187,600-12.0% Other 1,856,395 40,600 4472.4% Total 8,820,307 6,724,473 31. PTB DIP Prison Mainstream Other VALUE FOR MONEY Drug addiction leads to significant crime, health and social costs. Evidenced-based drug reduces these and delivers real savings, particularly in crime costs, but also in savings to the NHS through health improvements, reduced drug-related deaths and lower levels of blood-borne disease. This strong value for money case was recently endorsed by the Audit Office and is the foundation of central Government s significant ongoing investment. To help local areas assess the benefits this investment brings to them, the NTA s local Value for Money tool - which is already available to commissioners - provides value for money calculations using locally supplied financial data. This includes estimated crime and health savings, including number of crimes prevented. Designed to be flexible, the tool also allows areas to consider the consequences of disinvestment in terms of increased crime and disorder, poorer health outcomes, increased risk to communities and poorer outcomes for families with multiple needs. To ensure that maximum value is gained from every pound spent, the NTA s Cost Effectiveness Tool compares locally supplied costs data for against the costs in other areas. These products are based on work that has been approved by senior economists in the Home Office and Department of Health. PREVALENCE ESTIMATES The estimated number of opiate and/or crack users (OCU) and injectors in your area is set out below. Collectively, they have a big impact on crime, unemployment, safeguarding children and welfare dependency. Prevalence estimates (Aged from 15-64) OCU n 3,337 Rate per 1000 7.5 Rate per n 1000 306,150 8.9 OCU rate Opiate rate Crack rate Injecting rate per 1000 Opiate 2,689 6.1 264,072 7.7 Crack 1,419 3.2 184,247 5.4 Injecting 1,275 2.9 103,185 3.0 PAGE 2 OF 5

WAITING TIMES This data shows the number of drug users who waited no more than three weeks to access. Drug users need prompt help if they are to recover from dependency. efforts to keep waiting times low means that the national average waiting time is less than one week. Keeping waiting times low will play a vital role in supporting recovery in local communities. The number of drug users waiting more than six weeks to start has also been provided. 660 Adults waiting under three weeks to start 1 Adults waiting over six weeks to start 660 <5 all initial waits 99% 66,358 0% 478 1% all initial waits 97% 1% 3% Proportion waiting under three weeks TREATMENT ENGAGEMENT When engaged in, people use fewer illegal drugs, commit less crime, improve their health, and manage their lives better which also benefits the community. Preventing early drop out and keeping people in long enough to benefit contributes to these improved outcomes. As people progress through, the benefits to them, their families and their community start to accrue. The information below shows the proportion of adults in your area in 2011-12 who have been in for three months or more a measure for effective engagement. The numbers of individuals in 'effective ' based on the proportion of the national reported by your area is part of the calculation for local PTB allocations. Your local commissioning lead can provide more detail about how this funding works. Adults effectively engaged in 2011-12 #### Opiate 239 #### Growth Growth from from 10-10-11 11 1701 1% 88% 152,722-3% 8 239 13% 1 32,706-1% 18% 1940 95% 185,428-3% 5% 6% in effective IN TREATMENT The data below is drawn from the Treatment Outcomes Profile (TOP), which tracks the progress drug users make in. This includes information on rates of abstinence from drugs and statistically significant reductions in drug use and injecting, and those successfully leaving with secure housing and in work. If there is missing data below, this denotes less than 80% compliance with the TOP. The threshold is set to ensure that any conclusions drawn from the data are generalizable to the entire in within the partnership. Abstinence 151 Opiate abstinence 151Opiate 46% 46% Abstinence 35 Crack abstinence 35 Crack 80% 53% 11 Cocaine abstinence 11ocaine 69% 63% Opiate Crack Cocaine Significant reductions in use 96 Opiate significant reductions in use 96Opiate 1 Crack significant reductions in use <5 Crack 4 Cocaine significant reductions in use <5ocaine 30% 23% 11% 25% 9% Significant reductions in use Opiate Crack Cocaine Injecting use, housing need and employment 87 Adults no longer injecting at review 87 60% 6 adults no longer injecting at review 62 Adults successfully completing no longer reporting a housing need 62 91% 85% 93 Adults working ten or more days in the month before successfully completing 93 3 40% 38% 25% PAGE 3 OF 5

SUCCESSFUL COMPLETIONS The data below shows the proportion of drug users who complete their free of dependency, the progress your area has made on people successfully completing, and those successfully completing who do not relapse and re-enter. The drug strategy asks local areas to increase the number of people successfully leaving having overcome dependency. Although many individuals will require a number of separate episodes spread over many years, most individuals who complete successfully do so within two years of entry. Also below is the proportion of adults who have been in for more than two years a measure of longer term cases. If the proportion of long term cases in your area exceeds the national average, this may prompt a consideration of your local system s efforts to ensure that all the drug users it treats have the best chance of achieving abstinence from their drug of dependence. Successful completions as a proportion of total number in Proportion who successfully completed and did not return within 6 months Growth in successful completions since 2010-11 Opiate 9% 9% 58% 15% 41% 15% Opiate 78% 80% 84% 86% Opiate 1% 10% 49% 4% 20% 7% Opiate Opiate Opiate adults in for more than two years Opiate 54% 47% 53% 6% 44% Opiate RESIDENTIAL REHAB The data below shows the number of adult drug users in your area who have been to residential rehab during their latest period of (as a proportion of your whole and against the national proportion). Drug mostly takes place in the community, near to users families and support networks. However, in line with NICE recommendations, a stay in residential rehab is appropriate for the most serious cases, and local areas are encouraged to provide this option as part of an integrated recovery-orientated system. 9 Number of adults who attended residential rehab 9 0% 4,026 100% 98% PRESCRIPTION ONLY MEDICINE/OVER THE COUNTER MEDICINE (POM/OTC) People in for prescription-only medicines (POM) or over the counter medicines (OTC), and drug users who have a problem with these as well as illicit drugs are presented below. The drug strategy encourages local areas to ensure their services have the capacity to help people get the support that they need for POM and OTC dependence. 213 Illicit use Number of adults 21 citing POM/OTC use No illicit use 234 Total 213 10% 28,618 15% 21 1% 4,048 234 11% 32,666 17% 89% 83% citing POM/OTC use PAGE 4 OF 5

BLOOD-BORNE VIRUSES AND DRUG-RELATED DEATHS The data below shows the drug users in in your area who have had a hepatitis B vaccination and current or past injectors who have been tested for hepatitis C. Drug users who inject can spread blood-borne viruses. Providing methadone and sterile needles and syringes protects them and communities, and provides long-term health savings. Statistics about drug-related deaths in your area are not provided. However, preventing more of these deaths will be an important measure of how well your recovery-orientated drug system is doing. 173 Adults new to eligible for a HBV vaccination who accepted one 173 eligible clients 37% 23,436 eligible clients 48% #### Previous or current injectors eligible for a HCV test who received one 1,177 86% 73,556 70% PARENTS AND FAMILIES The data below shows the number of drug users in who live with children; users who are parents but do not live with children; and users for whom there is incomplete data. This last item is included to help you consider the possible hidden (s) of drug-dependent parents, or those with childcare responsibilities in contact with local services. An estimated one in three of the English, (65,481 people), has a child living with them at least some of the time. 579 Adults who live with children 579 28% 66,193 34% adults in who live with children 624 Adults who are parents but do not live with any children 624 31% 39,587 20% 18 Adults with incomplete data 18 1% 6,287 3% 7 66% PAGE 5 OF 5